Logo image of QTEK

QUALTEK SERVICES INC-A (QTEK) Stock Fundamental Analysis

USA - NASDAQ:QTEK - US74760R3030 - Common Stock

0.075 USD
-0.01 (-16.29%)
Last: 6/1/2023, 8:22:17 PM
0.0798 USD
+0 (+6.4%)
After Hours: 6/1/2023, 8:22:17 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to QTEK. QTEK was compared to 52 industry peers in the Construction & Engineering industry. QTEK may be in some trouble as it scores bad on both profitability and health. QTEK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QTEK had negative earnings in the past year.
In the past year QTEK has reported a negative cash flow from operations.
QTEK Yearly Net Income VS EBIT VS OCF VS FCFQTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -20M -40M -60M

1.2 Ratios

QTEK has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
QTEK Yearly ROA, ROE, ROICQTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 0 20 40 60 80

1.3 Margins

With a Gross Margin value of 11.75%, QTEK perfoms like the industry average, outperforming 46.15% of the companies in the same industry.
The Profit Margin and Operating Margin are not available for QTEK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.75%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QTEK Yearly Profit, Operating, Gross MarginsQTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 5 -5 10

More info and screens

0

2. Health

2.1 Basic Checks

QTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, QTEK has more shares outstanding
QTEK has a worse debt/assets ratio than last year.
QTEK Yearly Shares OutstandingQTEK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 10M 20M 30M 40M 50M
QTEK Yearly Total Debt VS Total AssetsQTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 200M 400M 600M

2.2 Solvency

QTEK has an Altman-Z score of -0.36. This is a bad value and indicates that QTEK is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.36, QTEK is doing worse than 82.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.36
ROIC/WACCN/A
WACC14.52%
QTEK Yearly LT Debt VS Equity VS FCFQTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 50M -50M 100M

2.3 Liquidity

QTEK has a Current Ratio of 0.36. This is a bad value and indicates that QTEK is not financially healthy enough and could expect problems in meeting its short term obligations.
QTEK has a Current ratio of 0.36. This is amonst the worse of the industry: QTEK underperforms 89.74% of its industry peers.
A Quick Ratio of 0.35 indicates that QTEK may have some problems paying its short term obligations.
QTEK has a Quick ratio of 0.35. This is amonst the worse of the industry: QTEK underperforms 89.74% of its industry peers.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.35
QTEK Yearly Current Assets VS Current LiabilitesQTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 200M 400M 600M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for QTEK have decreased strongly by -199.37% in the last year.
EPS 1Y (TTM)-199.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.09%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, QTEK will show a very strong growth in Earnings Per Share. The EPS will grow by 34.13% on average per year.
The Revenue is expected to grow by 9.84% on average over the next years. This is quite good.
EPS Next Y-23.64%
EPS Next 2Y12.82%
EPS Next 3Y38.78%
EPS Next 5Y34.13%
Revenue Next Year15.38%
Revenue Next 2Y13.68%
Revenue Next 3Y11.46%
Revenue Next 5Y9.84%

3.3 Evolution

QTEK Yearly Revenue VS EstimatesQTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
QTEK Yearly EPS VS EstimatesQTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QTEK. In the last year negative earnings were reported.
Also next year QTEK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QTEK Price Earnings VS Forward Price EarningsQTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, QTEK is valued a bit more expensive than the industry average as 64.10% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 31.11
QTEK Per share dataQTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

QTEK's earnings are expected to grow with 38.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.82%
EPS Next 3Y38.78%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for QTEK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUALTEK SERVICES INC-A

NASDAQ:QTEK (6/1/2023, 8:22:17 PM)

After market: 0.0798 +0 (+6.4%)

0.075

-0.01 (-16.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)05-16 2023-05-16/amc
Earnings (Next)N/A N/A
Inst Owners3.79%
Inst Owner Change-13.77%
Ins Owners0.13%
Ins Owner Change0%
Market Cap2.09M
Analysts80
Price Target3.57 (4660%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-1374.51%
Min EPS beat(2)-1374.51%
Max EPS beat(2)-1374.51%
EPS beat(4)1
Avg EPS beat(4)-401.2%
Min EPS beat(4)-1374.51%
Max EPS beat(4)195.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.24%
Min Revenue beat(2)-3.41%
Max Revenue beat(2)-3.06%
Revenue beat(4)2
Avg Revenue beat(4)1.03%
Min Revenue beat(4)-3.41%
Max Revenue beat(4)5.63%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-43.18%
EPS NY rev (1m)0%
EPS NY rev (3m)-23.64%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.54%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA 31.11
EPS(TTM)-1.57
EYN/A
EPS(NY)-0.69
Fwd EYN/A
FCF(TTM)-2.68
FCFYN/A
OCF(TTM)-2.46
OCFYN/A
SpS27.11
BVpS-1.89
TBVpS-13.98
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 11.75%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 31.02
Cap/Depr 10.4%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.36
Quick Ratio 0.35
Altman-Z -0.36
F-Score3
WACC14.52%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-199.37%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-57.09%
EPS Next Y-23.64%
EPS Next 2Y12.82%
EPS Next 3Y38.78%
EPS Next 5Y34.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year15.38%
Revenue Next 2Y13.68%
Revenue Next 3Y11.46%
Revenue Next 5Y9.84%
EBIT growth 1Y-904.42%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year424%
EBIT Next 3Y94.1%
EBIT Next 5Y66.49%
FCF growth 1Y-4331.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3971.03%
OCF growth 3YN/A
OCF growth 5YN/A